Clinical trial
CD133+ Autologous Cells After Myocardial Infarction
NCT00400959 · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Other · Completed
Key facts
| NCT number | NCT00400959 |
|---|---|
| Title | CD133+ Autologous Cells After Myocardial Infarction |
| Official title | Intracoronary Injection of CD133+ Autologous Hematopoietic Cells After Myocardial Infarction |
| Lead sponsor | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction |
| Intervention type | Procedure |
| Interventions | cd133+cell intracoronary administration |
| Enrollment | 15 |
| Start date | Jun 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Nov 17, 2006 |
| Last update posted | Nov 17, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: